Brian M. Gallagher

NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA.

CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA.

Part of Bracco SpA, Squibb Diagnostics is an American company that specializes in imaging diagnostics products. Squibb Diagnostics was acquired by Bracco SpA from Bristol Myers Squibb Co. on October 19, 1994.

Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA.

PPD Dermatology LLC develops novel pharmaceutical products and proprietary medical therapies for the dermatology market. The company provides therapies for skin diseases. It was founded in 2006 and is headquartered in Waltham, MA.

Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA.

IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA.